Invention Grant
- Patent Title: Nucleoside phosphoramidate compound and use thereof
-
Application No.: US14764865Application Date: 2014-03-06
-
Publication No.: US09963480B2Publication Date: 2018-05-08
- Inventor: Yong Wang , Liwen Zhao , Xian Zhang , Sheng Bi , Yiping Gao , Hongyan Chen , Dezhong Wang , Yang Nan , Cang Zhang , Yuxiu Li , Di Zhang
- Applicant: NANJING SANHOME PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Jiangsu
- Assignee: NANJING SANHOME PHARMACEUTICAL CO., LTD.
- Current Assignee: NANJING SANHOME PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Jiangsu
- Agency: Oliff PLC
- Priority: CN201310075423 20130308
- International Application: PCT/CN2014/073004 WO 20140306
- International Announcement: WO2014/135107 WO 20140912
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; C07H19/10 ; C07H19/048
Abstract:
A novel nucleoside phosphoramidate compound of the formula below, or a stereoisomer, salt, hydrate, solvate or crystal thereof for the treatment of Flaviviridae family viral infection, especially hepatitis C viral infection, and having a good anti-HCV effect; a pharmaceutical composition having the compound, or a stereoisomer, salt, hydrate, solvate or crystal thereof:
Public/Granted literature
- US20150361123A1 NOVEL NUCLEOSIDE PHOSPHORAMIDATE COMPOUND AND USE THEREOF Public/Granted day:2015-12-17
Information query
IPC分类:
